| Aktsiad | 655,878 mld. | - | KoAct | 0 | Tervishoid | | 3.8.2023 | 23 219,54 | 9,78 | 37,04 |
| Aktsiad | 328,226 mld. | - | Tiger ETF | 0,40 | Tervishoid | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 6.10.2020 | 9038,66 | 5,68 | 62,93 |
| Aktsiad | 316,058 mld. | - | KODEX | 0,45 | Tervishoid | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 13 128,28 | 6,80 | 37,93 |
| Aktsiad | 225,364 mld. | - | Tiger ETF | 0,40 | Tervishoid | KRX Healthcare - KRW | 15.7.2011 | 52 377,50 | 5,37 | 46,27 |
| Aktsiad | 106,308 mld. | - | KODEX | 0,09 | Tervishoid | KRX Healthcare - KRW | 28.3.2017 | 23 740,79 | 5,37 | 46,25 |
| Aktsiad | 103,444 mld. | - | Tiger ETF | 0,30 | Tervishoid | NASDAQ Biotechnology Index | 26.8.2014 | 30 750,34 | 5,37 | 23,71 |
| Aktsiad | 96,4 mld. | - | Tiger ETF | 0,40 | Tervishoid | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 14.12.2016 | 19 464,44 | 11,87 | 59,10 |
| Aktsiad | 67,448 mld. | - | Tiger ETF | 0,49 | Tervishoid | Solactive China Biotech Index | 3.12.2020 | 8809,96 | 4,34 | 39,11 |
| Aktsiad | 65,098 mld. | - | KODEX | 0,25 | Tervishoid | S&P Health Care Select Sector | 21.3.2023 | 13 550,76 | 5,12 | 23,06 |
| Aktsiad | 58,604 mld. | - | KB RISE | 0 | Tervishoid | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 15 760,57 | 9,56 | 68,04 |
| Aktsiad | 54,038 mld. | - | Tiger ETF | 0,45 | Tervishoid | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 10 599,79 | 10,72 | 21,80 |
| Aktsiad | 51,547 mld. | - | KODEX | 0,45 | Tervishoid | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 11 225,95 | 6,18 | 16,57 |
| Aktsiad | 41,242 mld. | 11,96 mln. | SPDR | 0,08 | Tervishoid | S&P Health Care Select Sector | 16.12.1998 | 157,68 | 5,11 | 22,91 |
| Aktsiad | 37,658 mld. | - | Tiger ETF | 0,40 | Tervishoid | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 24 336,77 | 3,42 | 40,82 |
| Aktsiad | 31,5 mld. | - | Tiger ETF | 0 | Tervishoid | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 29.6.2016 | 26 290,67 | 0 | 0 |
| Aktsiad | 28,184 mld. | - | Hwabao | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,36 | 3,06 | 30,88 |
| Aktsiad | 20,442 mld. | - | KODEX | 0,25 | Tervishoid | S&P Biotechnology Select Industry | 31.10.2013 | 38 346,27 | 0 | 0 |
| Aktsiad | 18,222 mld. | - | NH-Amundi | 0 | Tervishoid | | 26.11.2024 | 16 338,62 | 6,05 | 41,72 |
| Aktsiad | 18,099 mld. | - | E Fund | 0 | Tervishoid | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,39 | 3,37 | 26,68 |
| Aktsiad | 17,246 mld. | 269 668,6 | Vanguard | 0,09 | Tervishoid | MSCI US IMI 25/50 Health Care | 26.1.2004 | 290,45 | 4,95 | 23,18 |
| Aktsiad | 15,293 mld. | - | KoAct | 0,50 | Tervishoid | | 11.11.2025 | 10 166,93 | 5,77 | 0 |
| Aktsiad | 11,103 mld. | - | KB RISE | 0 | Tervishoid | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 18 322,54 | 5,38 | 42,23 |
| Aktsiad | 9,01 mld. | - | ACE | 0,30 | Tervishoid | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 13 003,95 | 7,82 | 23,23 |
| Aktsiad | 8,828 mld. | - | Kiwoom | 0,49 | Tervishoid | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 13 325,62 | 0 | 0 |
| Aktsiad | 8,812 mld. | - | ACE | 0,45 | Tervishoid | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 12 412,76 | 4,01 | 26,25 |
| Aktsiad | 8,443 mld. | 1,726 mln. | iShares | 0,44 | Tervishoid | NYSE Biotechnology (TR) | 5.2.2001 | 172,56 | 5,58 | 24,85 |
| Aktsiad | 8,438 mld. | 9,098 mln. | SPDR | 0,35 | Tervishoid | S&P Biotechnology Select Industry | 31.1.2006 | 122,85 | 4,95 | 0 |
| Aktsiad | 7,192 mld. | - | Tiger ETF | 0,50 | Tervishoid | FnGuide Medical Device Index - KRX - Benchmark TR Net | 7.11.2018 | 20 374,28 | 3,20 | 22,58 |
| Aktsiad | 6,872 mld. | - | ChinaAMC | 0,65 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,84 | 3,00 | 21,32 |
| Aktsiad | 6,767 mld. | - | Bosera | 0,65 | Tervishoid | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,64 | 2,75 | 12,80 |
| Aktsiad | 6,67 mld. | - | Maxwealth | 0,60 | Tervishoid | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,51 | 2,65 | 31,19 |
| Aktsiad | 5,785 mld. | - | Kiwoom | 0,49 | Tervishoid | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 11 632,01 | 4,74 | 18,54 |
| Aktsiad | 5,763 mld. | - | NEXT FUNDS | 0,32 | Tervishoid | | 21.3.2008 | 32 361,52 | 1,93 | 25,33 |
| Aktsiad | 5,546 mld. | - | KoAct | 0,50 | Tervishoid | | 3.9.2024 | 12 216,91 | 4,50 | 18,69 |
| Aktsiad | 5,49 mld. | - | KB RISE | 0,35 | Tervishoid | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 10 053,39 | 8,99 | 20,36 |
| Aktsiad | 5,441 mld. | - | Nippon | 0,19 | Tervishoid | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,59 | 31,47 |
| Aktsiad | 4,975 mld. | - | Invesco | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,69 | 3,45 | 24,61 |
| Aktsiad | 4,915 mld. | - | Tiger ETF | 0,40 | Tervishoid | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12 065,00 | 0 | 0 |
| Aktsiad | 4,756 mld. | - | ICBC | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,25 | 0 | 0 |
| Aktsiad | 4,693 mld. | - | ChinaAMC | 0,75 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,93 | 3,56 | 28,98 |
| Aktsiad | 4,693 mld. | - | ChinaAMC | 0,75 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,93 | 3,56 | 28,98 |
| Aktsiad | 4,538 mld. | 279 676,9 | iShares | 0,40 | Tervishoid | S&P Global 1200 / Health Care -SEC | 13.11.2001 | 100,99 | 4,70 | 23,01 |
| Aktsiad | 4,382 mld. | - | E Fund | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,40 | 0 | 0 |
| Aktsiad | 3,77 mld. | - | Guotai | 0,60 | Tervishoid | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 1,02 | 0 | 0 |
| Aktsiad | 3,606 mld. | - | Xtrackers | 0,25 | Tervishoid | MSCI World Index / Health Care -SEC | 22.11.2010 | 60,26 | 4,78 | 22,84 |
| Aktsiad | 3,495 mld. | 1,645 mln. | iShares | 0,38 | Tervishoid | DJ US Select / Medical Equipment | 1.5.2006 | 57,97 | 4,18 | 26,55 |
| Aktsiad | 3,366 mld. | 703 053,1 | iShares | 0,38 | Tervishoid | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 65,75 | 5,20 | 23,41 |
| Aktsiad | 3,365 mld. | - | Fullgoal | 0,60 | Tervishoid | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,44 | 0 | 0 |
| Aktsiad | 2,915 mld. | 183 916,4 | Fidelity | 0,08 | Tervishoid | MSCI US IMI 25/50 Health Care | 21.10.2013 | 74,99 | 5,00 | 23,10 |
| Aktsiad | 2,739 mld. | - | iShares | 0,15 | Tervishoid | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 12,63 | 5,15 | 23,07 |
| Aktsiad | 2,735 mld. | - | NH-Amundi | 0,45 | Tervishoid | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9115,65 | 3,43 | 26,31 |
| Aktsiad | 2,396 mld. | - | Hwabao | 0 | Tervishoid | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | - | 4,57 mld. | 0 | 0 |
| Aktsiad | 2,348 mld. | 123 159 | First Trust | 0,54 | Tervishoid | NYSE Arca Biotechnology Index | 19.6.2006 | 208,06 | 3,63 | 25,32 |
| Aktsiad | 2,311 mld. | - | Guotai | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,45 | 3,06 | 30,91 |
| Aktsiad | 1,875 mld. | - | Ping An | 0,60 | Tervishoid | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,37 | 4,10 | 25,08 |
| Aktsiad | 1,701 mld. | - | E Fund | 0,20 | Tervishoid | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,14 | 2,50 | 20,25 |
| Aktsiad | 1,636 mld. | - | Harvest ETFs | 1,06 | Tervishoid | | 19.11.2014 | 7,65 | 4,93 | 21,81 |
| Aktsiad | 1,562 mld. | - | iShares | 0,18 | Tervishoid | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 7,59 | 4,24 | 21,39 |
| Aktsiad | 1,49 mld. | - | Amundi | 0,50 | Tervishoid | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9937,75 | 2,82 | 14,76 |
| Aktsiad | 1,459 mld. | - | Cathay | 1,05 | Tervishoid | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 8,13 | 3,36 | 18,14 |
| Aktsiad | 1,44 mld. | - | Guotai | 0,60 | Tervishoid | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 0,89 | 0 | 0 |
| Aktsiad | 1,435 mld. | - | iShares | 0,46 | Tervishoid | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 141,20 | 0 | 0 |
| Aktsiad | 1,413 mld. | - | E Fund | 0,20 | Tervishoid | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,51 | 2,78 | 29,20 |
| Aktsiad | 1,388 mld. | - | E Fund | 0,20 | Tervishoid | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,42 | 4,33 | 29,55 |
| Aktsiad | 1,289 mld. | 424 786,2 | VanEck | 0,36 | Tervishoid | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 111,16 | 5,21 | 20,15 |
| Aktsiad | 1,227 mld. | - | E Fund | 0,20 | Tervishoid | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,67 | 3,12 | 28,62 |
| Aktsiad | 1,175 mld. | - | Xtrackers | 0,12 | Tervishoid | MSCI USA / Health Care -SEC | 12.9.2017 | 63,58 | 5,31 | 23,12 |
| Aktsiad | 1,175 mld. | - | Xtrackers | 0,12 | Tervishoid | MSCI USA / Health Care -SEC | 12.9.2017 | 63,58 | 5,31 | 23,12 |
| Aktsiad | 1,084 mld. | - | Harvest | 0,60 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 0,90 | 0 | 0 |
| Aktsiad | 1,032 mld. | 107 236 | iShares | 0,38 | Tervishoid | DJ US Select / Pharmaceutical | 1.5.2006 | 90,39 | 4,78 | 24,04 |
| Aktsiad | 968,478 mln. | - | Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 161,03 | 3,16 | 19,03 |
| Aktsiad | 968,478 mln. | - | Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 161,03 | 3,16 | 19,03 |
| Aktsiad | 956,334 mln. | - | Global X | 0,59 | Tervishoid | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1686,36 | 2,09 | 21,22 |
| Aktsiad | 921,034 mln. | - | CSOP | 1,50 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 3,79 | 3,52 | 28,95 |
| Aktsiad | 911,302 mln. | - | iShares | 0,35 | Tervishoid | NASDAQ Biotechnology Index | 19.10.2017 | 8,62 | 0 | 0 |
| Aktsiad | 906,152 mln. | 29 986,87 | First Trust | 0,62 | Tervishoid | StrataQuant Health Care Index | 8.5.2007 | 114,72 | 2,84 | 16,99 |
| Aktsiad | 904,346 mln. | - | Wanjia | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,63 | 3,45 | 24,61 |
| Aktsiad | 778,417 mln. | - | Amundi | 0,30 | Tervishoid | MSCI World Index / Health Care -SEC | 19.8.2010 | 490,76 | 7,68 | 29,88 |
| Aktsiad | 758,498 mln. | - | iShares | 0,46 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 121,03 | 4,16 | 21,44 |
| Aktsiad | 754,036 mln. | 93 317,16 | Invesco | 0,40 | Tervishoid | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 32,53 | 3,30 | 21,29 |
| Aktsiad | 718,754 mln. | 299 436,1 | iShares | 0,38 | Tervishoid | DJ US Select / Health Care Providers | 1.5.2006 | 46,31 | 2,26 | 16,51 |
| Aktsiad | 709,881 mln. | - | Cathay | 0,41 | Tervishoid | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 30,59 | 0 | 0 |
| Aktsiad | 678,658 mln. | - | SPDR | 0,18 | Tervishoid | MSCI Europe Health Care Index - EUR | 5.12.2014 | 241,07 | 4,25 | 21,39 |
| Aktsiad | 673,31 mln. | - | Global X | 0,68 | Tervishoid | Solactive China Biotech Index | 25.7.2019 | 72,58 | 4,53 | 43,83 |
| Aktsiad | 673,31 mln. | - | Global X | 0,68 | Tervishoid | Solactive China Biotech Index | 25.7.2019 | 72,58 | 4,53 | 43,83 |
| Aktsiad | 665,821 mln. | - | SPDR | 0,30 | Tervishoid | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 29.4.2016 | 69,57 | 5,08 | 25,68 |
| Aktsiad | 586,928 mln. | - | China Southern | 0,65 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,21 | 2,97 | 21,35 |
| Aktsiad | 577,074 mln. | - | SPDR | 0,15 | Tervishoid | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 48,70 | 5,11 | 22,91 |
| Aktsiad | 569,891 mln. | - | iShares | 0,66 | Tervishoid | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 72,34 | 0 | 0 |
| Aktsiad | 567,516 mln. | - | ChinaAMC | 0,60 | Tervishoid | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 23.11.2023 | 0,88 | 2,65 | 31,16 |
| Aktsiad | 546,644 mln. | 608 183,1 | Direxion | 0,93 | Tervishoid | S&P Biotechnology Select Industry | 28.5.2015 | 155,90 | 0 | 0 |
| Aktsiad | 541,219 mln. | - | Fullgoal | 0,60 | Tervishoid | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,94 | 0 | 0 |
| Aktsiad | 504,863 mln. | - | Guotai | 0,60 | Tervishoid | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,76 | 3,51 | 27,58 |
| Aktsiad | 429,75 mln. | - | Invesco | 0,40 | Tervishoid | NASDAQ / Biotechnology | 6.11.2014 | 61,58 | 5,34 | 23,31 |
| Aktsiad | 427,69 mln. | - | China Southern | 0,20 | Tervishoid | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,66 | 3,12 | 28,62 |
| Aktsiad | 421,796 mln. | - | Maxwealth | 0,60 | Tervishoid | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,53 | 0 | 0 |
| Aktsiad | 418,426 mln. | 46 155,16 | Invesco | 0,57 | Tervishoid | Dynamic Pharmaceutical Intellidex Index (AMEX) | 23.6.2005 | 109,58 | 3,10 | 19,80 |
| Aktsiad | 405,418 mln. | - | Invesco | 0,14 | Tervishoid | S&P Select Sector Capped 20% Health Care Index | 16.12.2009 | 776,99 | 5,10 | 22,93 |
| Aktsiad | 381,03 mln. | 6857,645 | VanEck | 0,35 | Tervishoid | MVIS US Listed Biotech 25 | 20.12.2011 | 195,17 | 5,01 | 24,93 |
| Aktsiad | 337,286 mln. | - | Amundi | 0,18 | Tervishoid | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index - EUR - Benchmark TR Net | 20.9.2022 | 11,35 | 5,17 | 23,05 |